IP Library Granted Patent US 9,795,633
Granted Patent B2
US 9,795,633 · App. 15/179,815 · Granted Oct 24, 2017

Topical and oral formulations comprising taurine and magnesium for the prevention and treatment of acne

Inventor: Margaret Jean Profet (Manhattan Beach, CA)
A61K33/08A61K8/00A61K9/0014A61K9/0053A61K9/06A61K31/185A61K33/06A61K45/06
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,795,633
App. No.
15/179,815
Granted
Oct 24, 2017
Kind
B2
Abstract

Topical and oral compositions for treating and/or preventing acne are disclosed. The compositions include effective amounts of taurine and magnesium, wherein the effective amounts are sufficient to treat and/or prevent the acne. A method for treating and/or preventing acne in a subject in need thereof is also disclosed. The method includes administering to the subject topical and/or oral compositions including taurine and magnesium in amounts sufficient to treat and/or prevent the acne.

Claims (23)

1. A combination for treating and/or preventing an acne condition, the combination comprising an effective amount of taurine and an effective amount of magnesium in an oral dosage form, wherein the combination of the effective amounts of taurine and magnesium are sufficient to treat and/or prevent the acne condition, and wherein the effective amount of taurine is in a range of about 500 mg to about 3000 mg per unit dose, and the effective amount of magnesium is in a range of about 25 mg to about 500 mg per unit dose.

2. The combination of claim 1 , wherein the effective amounts of taurine and magnesium are provided together in a single oral supplement.

3. The combination of claim 2 , wherein the single oral supplement is a capsule or a tablet or a unit dose of powder.

4. The combination of claim 1 , further comprising a pharmaceutically acceptable carrier.

5. The combination of claim 1 , further comprising one or more micronutrients selected from the group consisting of vitamin D, vitamin A, zinc, choline, vitamin B1, vitamin B2, vitamin B3, vitamin B5, vitamin C, vitamin E, vitamin K, Folic Acid, Calcium, Iron, Phosphorous, Iodine, Potassium, Selenium, Manganese, Copper, Inositol, Omega 3 fatty acids, Lycopene, Lutein, and Zeaxanthin.

6. A method for treating and/or preventing an acne condition in a subject in need thereof, the method comprising orally administering to the subject an effective amount of taurine and an effective amount of magnesium simultaneously or sequentially, wherein the effective amounts are sufficient in combination to treat and/or prevent the acne condition, wherein the effective amount of taurine is in a range of about 500 mg to about 6000 mg per day, and the effective amount of magnesium is in a range of about 50 mg to about 500 mg per day.

7. The method of claim 6 , wherein orally administering comprises administering the taurine and magnesium together in a form of a single oral supplement, selected from a capsule, a tablet or a unit dose of powder.

8. The method of claim 6 , further comprising assessing a severity of the acne condition, and varying a dose of administered taurine, magnesium, or both, such that lower dosages of taurine, magnesium, or both are administered in mild cases of the acne condition and higher dosages of taurine, magnesium, or both are administered in severe cases of the acne condition.

9. The method of claim 8 , wherein the dose is a single daily dose or a multiple daily dose.

10. The method of claim 6 , further comprising administering one or more micronutrients selected from the group consisting of vitamin A, vitamin B1, vitamin B2, vitamin B3, vitamin B5, vitamin B6, vitamin B12, vitamin C, vitamin D, vitamin E, vitamin K, Folic Acid, Biotin, Calcium, Iron, Phosphorous, Iodine, Potassium, Zinc, Selenium, Manganese, Copper, Choline, Inositol, Omega 3 fatty acids, Lycopene, Lutein and Zeaxanthin.

11. The combination of claim 1 , wherein the effective amounts of taurine and magnesium are provided in separate oral supplements.

12. The combination of claim 11 , wherein the separate oral supplements are in the form of tablets, capsules or powder.

13. The method of claim 6 , wherein the effective amounts of taurine and magnesium are administered in separate oral supplements.

14. The method of claim 13 , wherein the separate oral supplements are in the form of tablets, capsules or powder.

15. A combination for treating and/or preventing an acne condition, the combination comprising an effective amount of taurine and an effective amount of magnesium in a topical gel or a topical cream, wherein the combination of the effective amounts of taurine and magnesium are sufficient to treat and/or prevent the acne condition, and wherein the effective amount of taurine is in a range of about 200 mg to about 2000 mg per ½ teaspoon of the gel or cream, and the effective amount of magnesium is in a range of about 40 mg to about 400 mg per ½ teaspoon of the gel or cream.

16. A method for treating and/or preventing an acne condition in a subject in need thereof, the method comprising topically administering to the subject an effective amount of taurine and an effective amount of magnesium, wherein the effective amounts are sufficient in combination to treat and/or prevent the acne condition, wherein the effective amount of taurine is in a range of about 400 mg to about 4000 mg per day, and the effective amount of magnesium is in a range of about 25 mg to about 500 mg per day.

17. A method for treating and/or preventing an acne condition in a subject in need thereof, the method comprising:

orally administering to the subject an effective amount of taurine and an effective amount of magnesium simultaneously or sequentially, wherein the effective amounts are sufficient in combination to treat and/or prevent the acne condition, wherein the effective amount of taurine is in a range of about 500 mg to about 6000 mg per day, and the effective amount of magnesium is in a range of about 50 mg to about 500 mg per day; and

topically administering to the subject an effective amount of taurine and an effective amount of magnesium, wherein the effective amounts are sufficient in combination to treat and/or prevent the acne condition, wherein the effective amount of taurine is in a range of about 400 mg to about 4000 mg per day, and the effective amount of magnesium is in a range of about 25 mg to about 500 mg per day.

18. The combination of claim 15 , further comprising a pharmaceutically acceptable carrier.

19. The combination of claim 15 , further comprising one or more micronutrients selected from the group consisting of vitamin D, vitamin A, zinc, choline, vitamin B1, vitamin B2, vitamin B3, vitamin B5, vitamin C, vitamin E, vitamin K, Folic Acid, Calcium, Iron, Phosphorous, Iodine, Potassium, Selenium, Manganese, Copper, Inositol, Omega 3 fatty acids, Lycopene, Lutein, and Zeaxanthin.

20. The method of claim 16 , further comprising assessing a severity of the acne condition, and varying a dose of administered taurine, magnesium, or both, such that lower dosages of taurine, magnesium, or both are administered in mild cases of the acne condition and higher dosages of taurine, magnesium, or both are administered in severe cases of the acne condition.

21. The method of claim 16 , further comprising administering one or more micronutrients selected from the group consisting of vitamin A, vitamin B1, vitamin B2, vitamin B3, vitamin B5, vitamin B6, vitamin B12, vitamin C, vitamin D, vitamin E, vitamin K, Folic Acid, Biotin, Calcium, Iron, Phosphorous, Iodine, Potassium, Zinc, Selenium, Manganese, Copper, Choline, Inositol, Omega 3 fatty acids, Lycopene, Lutein and Zeaxanthin.

Assignments (1)
SECURITY INTEREST Recorded Jul 26, 2022
From: PROFET, MARGARET
To: KNOBBE, MARTENS, OLSON & BEAR, LLP
Reel/Frame 061497/0642 →
Continuity (2)
Provisional Application 62180842 · Jun 17, 2015
Related Publication 20160367596A1 · Dec 22, 2016